GB201602210D0 - Detection of cancer - Google Patents

Detection of cancer

Info

Publication number
GB201602210D0
GB201602210D0 GBGB1602210.5A GB201602210A GB201602210D0 GB 201602210 D0 GB201602210 D0 GB 201602210D0 GB 201602210 A GB201602210 A GB 201602210A GB 201602210 D0 GB201602210 D0 GB 201602210D0
Authority
GB
United Kingdom
Prior art keywords
cancer
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1602210.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1602210.5A priority Critical patent/GB201602210D0/en
Publication of GB201602210D0 publication Critical patent/GB201602210D0/en
Priority to PCT/EP2017/052730 priority patent/WO2017137427A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
GBGB1602210.5A 2016-02-08 2016-02-08 Detection of cancer Ceased GB201602210D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1602210.5A GB201602210D0 (en) 2016-02-08 2016-02-08 Detection of cancer
PCT/EP2017/052730 WO2017137427A1 (en) 2016-02-08 2017-02-08 Detection of cancer of the esophagus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1602210.5A GB201602210D0 (en) 2016-02-08 2016-02-08 Detection of cancer

Publications (1)

Publication Number Publication Date
GB201602210D0 true GB201602210D0 (en) 2016-03-23

Family

ID=55641956

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1602210.5A Ceased GB201602210D0 (en) 2016-02-08 2016-02-08 Detection of cancer

Country Status (2)

Country Link
GB (1) GB201602210D0 (en)
WO (1) WO2017137427A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108424965A (en) * 2018-04-24 2018-08-21 郑州大学第附属医院 A kind of cancer of pancreas prognosis molecule marker non-coding RNA Lnc-CRYBA4-23 and its application
CN109044283B (en) * 2018-08-31 2021-02-02 重庆高铂瑞骐科技开发有限公司 Esophagus functional disease diagnosis system based on multi-mode information
JP2020074769A (en) * 2018-11-01 2020-05-21 花王株式会社 Method for preparing nucleic acid derived from skin cells of subject
CN110093419B (en) * 2019-04-26 2023-10-27 北京大学深圳医院 Application of circular RNA, kit and pharmaceutical composition and application thereof
JP2023530391A (en) * 2020-05-19 2023-07-18 プロフェーズ ラボズ, インク. Systems and methods for markers defining development of Barrett's esophagus and progression of esophageal adenocarcinoma
CN113969318A (en) * 2021-11-10 2022-01-25 广东省人民医院 Application of combined tar death related gene in esophageal adenocarcinoma prognosis model

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070004725A (en) 2004-02-20 2007-01-09 더 리전츠 오브 더 유니버시티 오브 캘리포니아 Salivary mrna profiling, biomarkers and related methods and kits of parts
ES2379805T3 (en) * 2005-07-27 2012-05-03 Oncotherapy Science, Inc. ECT2 as a therapeutic target for esophageal cancer
EP2071336A1 (en) * 2007-12-13 2009-06-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma
GB201005048D0 (en) * 2010-03-24 2010-05-12 Medical Res Council Prognosis of oesophageal and gastro-oesophageal junctional cancer

Also Published As

Publication number Publication date
WO2017137427A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
ZA201900016B (en) Sensing of objects
GB201602319D0 (en) Proximity detection
GB201616912D0 (en) Classification of cancer
GB201719627D0 (en) Proximity detection
GB2571026B (en) Detection of PH
GB2545480B8 (en) Detection of coordinated cyber-attacks
GB201602210D0 (en) Detection of cancer
HK1260327A1 (en) Methods of detecting cancer recurrence
SG10201913528PA (en) Methods of diagnosing cancer
EP3191846A4 (en) Methods of detecting prostate cancer
SG11201701076TA (en) Diagnosis of cancer
EP3839513C0 (en) Use of dna-transcription factor complexes for cancer detection
IL257514A (en) Cancer detection method
IL247270B (en) Method of detecting cancer
GB201610708D0 (en) Detection of tailgating situations
SG11201702077RA (en) Kit for cancer detection
GB201508480D0 (en) Cancer
GB2546773B (en) Cancer
IL248126A0 (en) Combination of cancer therapeutics
HK1215285A1 (en) Marker useful for detection of intestinal cancer and the use thereof
SG10201603579PA (en) Methods Of Detecting Cancer
HK1246851A1 (en) Methods of detecting cancer
GB2552535B (en) Detection of scatter radiation
GB2551956B (en) Object detection
GB201400436D0 (en) Detection of brain cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)